Moderna Inc. and Merck & Co.’s cancer vaccine helped prevent relapse for melanoma patients, results from a midstage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system.
About 79% of high-risk melanoma patients who got the personalized vaccine and Merck’s immunotherapy Keytruda were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, researchers said Sunday. The 157-person trial offers some of the strongest evidence yet that such vaccines could benefit cancer patients.
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Already a subscriber? Sign In
Sponsored Offers
- Target:
Target Promo Code: 20% Off Entire Order - Vitacost:
Take 30% OFF select Move Free products with Vitacost Promo Code - Walmart:
20% off your order with Walmart promo code - Groupon:
Groupon Promo Code - 30% Off Activities, Dining, More - adidas:
adidas Promo Code - Up to 50% Off 3-Stripe Favorites - Nike:
Nike promo code: Members save up to 20% on select styles
